Inventor · disambiguated record
Min Zheng
Also filed as: ZHENG MIN · ZHENG MIN FENG
11 granted patents·11 pending applications·116 citations·filing 2001–2025
88Inventor score
Files withINSILICO MEDICINE IP LTD6BEIJING SINOGENE BIOTECHNOLOGY CO LTD3BECKMAN COULTER INC2COULTER INT CORP2UNIV ZHEJIANG2
Top patents by PatentIndex Score
22 records- 0188US6472215B1Method of analyzing nucleated red blood cells in a blood sampleCOULTER INT CORP·Filed 2001·Granted Oct 29, 2002·44 cites·19 claims
- 0287US8192995B2Method of correction of particle interference to hemoglobin measurementZHANG SHULIANG·Filed 2009·Granted Jun 5, 2012·29 cites·23 claims
- 0386US7457709B2Systems and methods for particle countingBECKMAN COULTER INC·Filed 2005·Granted Nov 25, 2008·21 cites·8 claims
- 0475US10041863B2Method of measuring carbonation levels in open-container beveragesPEPSICO INC·Filed 2015·Granted Aug 7, 2018·2 cites·18 claims
- 0573US7482165B2Method of preventing white blood cell interferences to red blood cell measurements of a blood sampleBECKMAN COULTER INC·Filed 2005·Granted Jan 27, 2009·9 cites·21 claims
- 0672US9827304B2Live attenuated vaccines for influenza virusesUNIV HONG KONG·Filed 2015·Granted Nov 28, 2017·1 cites·18 claims
- 0771US6744245B2Particle count correction method and apparatusCOULTER INT CORP·Filed 2001·Granted Jun 1, 2004·10 cites·16 claims
- 0864US2025340569A1Inhibitors of kif18a and uses thereofINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 0963US2025188094A1Pyrazole membrane-associated tyrosine-and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1063US2025163077A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1163US2025197405A1Heteroaromatic compounds as pkmyt1 inhibitors and use thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1262US2025145624A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1360US2025136596A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1457US11883482B2Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereofLANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 1555US2022369608A1Method for establishing diabetes disease model dogBEIJING SINOGENETIC BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1654US2025223643A1Reagent kit and sequencing method using the sameMGI TECH CO LTD·Filed 2025·Application pending·0 cites
- 1752US12056872B2Method for extracting significant texture features of B-ultrasonic image and application thereofUNIV ZHEJIANG·Filed 2021·Granted Aug 6, 2024·0 cites·6 claims
- 1851US2018279591A1Method for preparing a canine model of atherosclerosisBEIJING SINOGENE BIOTECHNOLOGY CO LTD·Filed 2017·Application pending·0 cites
- 1950US12305234B2Serum miRNA markers for diagnosing liver cancer and predicting liver cancer metastasis and detection kit thereofUNIV ZHEJIANG·Filed 2021·Granted May 20, 2025·0 cites·1 claims
- 2050US2022324977A1Anti-canine pd-1 antibody binding with canine pd-1BEIJING SINOGENE BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 2148US2019032086A1Method for preparing a gene knock-out canine with somatic cell cloning technologyBEIJING SINOGENE BIOTECHNOLOGY CO LTD·Filed 2018·Application pending·0 cites
- 2244US11123421B2Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal deliveryVERSITECH LTD·Filed 2017·Granted Sep 21, 2021·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Min Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →